HLA in transplantation
Autor: | Robert A. Montgomery, Vasishta S. Tatapudi, Mary S. Leffell, Andrea A. Zachary |
---|---|
Rok vydání: | 2018 |
Předmět: |
0301 basic medicine
Graft Rejection medicine.medical_specialty Histocompatibility Testing Human leukocyte antigen 030230 surgery Adaptive Immunity Organ transplantation Immune tolerance 03 medical and health sciences 0302 clinical medicine HLA Antigens medicine Immune Tolerance Humans Kidney transplantation Immunosuppression Therapy business.industry Acquired immune system medicine.disease Kidney Transplantation Transplantation Tolerance induction 030104 developmental biology Nephrology Desensitization Immunologic Immunology business |
Zdroj: | Nature reviews. Nephrology. 14(9) |
ISSN: | 1759-507X |
Popis: | The human major histocompatibility complex is a family of genes that encodes HLAs, which have a crucial role in defence against foreign pathogens and immune surveillance of tumours. In the context of transplantation, HLA molecules are polymorphic antigens that comprise an immunodominant alloreactive trigger for the immune response, resulting in rejection. Remarkable advances in knowledge and technology in the field of immunogenetics have considerably enhanced the safety of transplantation. However, access to transplantation among individuals who have become sensitized as a result of previous exposure to alloantigens is reduced proportional to the breadth of their sensitization. New approaches for crossing the HLA barrier in transplantation using plasmapheresis, intravenous immunoglobulin and kidney paired donation have been made possible by the relative ease with which even low levels of anti-HLA antibodies can now be detected and tracked. The development of novel protocols for the induction of tolerance and new approaches to immunomodulation was also facilitated by advances in HLA technology. Here, we review the progress made in understanding HLAs that has enabled organ transplantation to become a life-saving endeavour that is accessible even for sensitized patients. We also discuss novel approaches to desensitization, immunomodulation and tolerance induction that have the potential to further improve transplantation access and outcomes. |
Databáze: | OpenAIRE |
Externí odkaz: |